10-Year study to track rare brain disease in 500 koreans

NCT ID NCT07497867

Recruiting now Knowledge-focused Sponsor: Jeju National University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This 10-year study will follow 500 Korean adults with CADASIL, a genetic brain disease that causes strokes and dementia. Researchers will track symptoms, brain scans, memory tests, and genetic information to understand how the disease progresses in Koreans. The goal is to improve care for patients and families worldwide. No new treatment is being tested.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could reveal how CADASIL progresses in Korean patients and point toward better ways to manage the disease.
What could go wrong: This is an observational study, not a treatment trial. It will not test any new drug or therapy, so direct patient benefits are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CADASIL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral arteriopathy with subcortical infarcts and leukoencephalopathy cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy, type 1 Cerebral Small Vessel Diseases Leukoencephalopathies stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CADASIL CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATIE WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Jeju National University Hospital
RECRUITING

Jeju City, Jeju-do, 63241, South Korea

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.